BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31886938)

  • 1. Divergent effects of canonical and non-canonical TGF-β signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms.
    Pedroza AJ; Koyano T; Trojan J; Rubin A; Palmon I; Jaatinen K; Burdon G; Chang P; Tashima Y; Cui JZ; Berry G; Iosef C; Fischbein MP
    J Cell Mol Med; 2020 Feb; 24(3):2369-2383. PubMed ID: 31886938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm.
    Pedroza AJ; Tashima Y; Shad R; Cheng P; Wirka R; Churovich S; Nakamura K; Yokoyama N; Cui JZ; Iosef C; Hiesinger W; Quertermous T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2195-2211. PubMed ID: 32698686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
    Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
    J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.
    Crosas-Molist E; Meirelles T; López-Luque J; Serra-Peinado C; Selva J; Caja L; Gorbenko Del Blanco D; Uriarte JJ; Bertran E; Mendizábal Y; Hernández V; García-Calero C; Busnadiego O; Condom E; Toral D; Castellà M; Forteza A; Navajas D; Sarri E; Rodríguez-Pascual F; Dietz HC; Fabregat I; Egea G
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):960-72. PubMed ID: 25593132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
    Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome.
    Dale M; Fitzgerald MP; Liu Z; Meisinger T; Karpisek A; Purcell LN; Carson JS; Harding P; Lang H; Koutakis P; Suh M; Batra R; Mietus CJ; Casale G; Pipinos I; Baxter BT; Xiong W
    PLoS One; 2017; 12(10):e0186603. PubMed ID: 29040313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β mediates aortic smooth muscle cell senescence in Marfan syndrome.
    You W; Hong Y; He H; Huang X; Tao W; Liang X; Zhang Y; Li X
    Aging (Albany NY); 2019 May; 11(11):3574-3584. PubMed ID: 31147528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryologic Origin Influences Smooth Muscle Cell Phenotypic Modulation Signatures in Murine Marfan Syndrome Aortic Aneurysm.
    Pedroza AJ; Dalal AR; Shad R; Yokoyama N; Nakamura K; Cheng P; Wirka RC; Mitchel O; Baiocchi M; Hiesinger W; Quertermous T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2022 Sep; 42(9):1154-1168. PubMed ID: 35861960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth Muscle Cell Klf4 Expression Is Not Required for Phenotype Modulation or Aneurysm Formation in Marfan Syndrome Mice-Brief Report.
    Pedroza AJ; Dalal AR; Shad R; Yokoyama N; Nakamura K; Mitchel O; Gilles C; Hiesinger W; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):971-978. PubMed ID: 37128911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired vascular smooth muscle cell force-generating capacity and phenotypic deregulation in Marfan Syndrome mice.
    Nolasco P; Fernandes CG; Ribeiro-Silva JC; Oliveira PVS; Sacrini M; de Brito IV; De Bessa TC; Pereira LV; Tanaka LY; Alencar A; Laurindo FRM
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165587. PubMed ID: 31678158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad4 Deficiency in Smooth Muscle Cells Initiates the Formation of Aortic Aneurysm.
    Zhang P; Hou S; Chen J; Zhang J; Lin F; Ju R; Cheng X; Ma X; Song Y; Zhang Y; Zhu M; Du J; Lan Y; Yang X
    Circ Res; 2016 Feb; 118(3):388-99. PubMed ID: 26699655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice.
    Nakamura K; Dalal AR; Yokoyama N; Pedroza AJ; Kusadokoro S; Mitchel O; Gilles C; Masoudian B; Leipzig M; Casey KM; Hiesinger W; Uchida T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1134-1153. PubMed ID: 37078287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms.
    Gomez D; Coyet A; Ollivier V; Jeunemaitre X; Jondeau G; Michel JB; Vranckx R
    Cardiovasc Res; 2011 Feb; 89(2):446-56. PubMed ID: 20829218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation.
    Emrich F; Penov K; Arakawa M; Dhablania N; Burdon G; Pedroza AJ; Koyano TK; Kim YM; Raaz U; Connolly AJ; Iosef C; Fischbein MP
    J Cell Mol Med; 2019 Oct; 23(10):7000-7009. PubMed ID: 31402541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death.
    Granata A; Serrano F; Bernard WG; McNamara M; Low L; Sastry P; Sinha S
    Nat Genet; 2017 Jan; 49(1):97-109. PubMed ID: 27893734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.